Style de citation APA

Kashiwagi, S., Yashiro, M., Takashima, T., Aomatsu, N., Ikeda, K., Ogawa, Y., . . . Hirakawa, K. (2011). Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: Usefulness of prognostic markers E-cadherin and Ki67. BioMed Central.

Style de citation Chicago

Kashiwagi, Shinichiro, Masakazu Yashiro, Tsutomu Takashima, Naoki Aomatsu, Katsumi Ikeda, Yoshinari Ogawa, Tetsuro Ishikawa, et Kosei Hirakawa. Advantages of Adjuvant Chemotherapy for Patients With Triple-negative Breast Cancer At Stage II: Usefulness of Prognostic Markers E-cadherin and Ki67. BioMed Central, 2011.

Style de citation MLA

Kashiwagi, Shinichiro, et al. Advantages of Adjuvant Chemotherapy for Patients With Triple-negative Breast Cancer At Stage II: Usefulness of Prognostic Markers E-cadherin and Ki67. BioMed Central, 2011.

Attention : ces citations peuvent ne pas être correctes à 100%.